Duke Cancer Institute
Kevin Williams is the Merck Distinguished Professor in Integrated Biosciences and a Professor in the Department of Pharmaceutical Sciences at North Carolina Central University, where involvement in research focuses on Hedgehog signaling and breast cancer, as well as process analytical technology for downstream processing. Since 2007, Kevin has overseen eleven graduate students who completed their Masters Thesis research. Kevin holds membership at the UNC Lineberger Comprehensive Cancer Center and the Duke Cancer Institute and served as a Visiting Research Fellow at Lucy Cavendish College, University of Cambridge. Previous roles include Associate Director of Enzyme Drug Discovery at Amphora, Senior Scientist at Biogen focusing on protein engineering and drug discovery, and management and research positions at several biotech and pharmaceutical companies. Kevin earned a Ph.D. in Biochemistry from the University of Cambridge and completed postdoctoral research at Harvard Medical School.
This person is not in any teams
This person is not in any offices
Duke Cancer Institute
1 followers
Duke Cancer Institute is a collaborative powerhouse—audacious, evolving, unconventional—at the center of a world-renowned university and medical center. We unleash the power of synchronous collaboration to create breakthroughs that rapidly transform the unimagined into the possible—to fuel a pace of discoveries and advances previously thought impossible. Established in 1973 as one of the original eight comprehensive cancer centers designated by the National Cancer Institute (NCI), today our patients come for care from every county in North Carolina, every state in the nation and from around the world.